Synthetic Soluble Receptor Mimics and Methods of Use for Treatment of COVID-19
OwnerDaniel Kulpinventor
Life of this patent
Estimating the term…
Abstract
The present invention provides compositions comprising cellular receptor mimics and methods for treating or preventing coronavirus infection or a disease or disorder associated with coronavirus infection such as COVID-19.
Claims42
A composition comprising a nucleic acid molecule encoding at least one synthetic cellular receptor peptide which specifically binds to a coronavirus Spike antigen.
A composition comprising at least one synthetic cellular receptor peptide which specifically binds to a coronavirus Spike antigen.
A nucleic acid molecule comprising a nucleotide sequence encoding at least one synthetic cellular receptor peptide which specifically binds to a coronavirus Spike antigen.
A synthetic cellular receptor peptide which specifically binds to a coronavirus Spike antigen.
Dependencies are inferred from the claim text.